[1]
|
http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf
|
[2]
|
http://www.who.int/topics/hiv_aids/en/
|
[3]
|
Koralnik, I.J. (2004) New Insights into Progressive Multifocal Leukoencephalopathy. Current Opinion in Neurology, 17, 365-370. http://dx.doi.org/10.1097/00019052-200406000-00019
|
[4]
|
Nived, O., Bengtsson, A.A., Jönsen, A. and Sturfelt, G. (2008) Progressive Multifocal Leukoencephalopathy—The Importance of Early Diagnosis Illustrated in Four Cases. Lupus, 17, 1036-41.
|
[5]
|
Berger, J.R. and Koralnik, I.J. (2005) Progressive Multifocal Leukoencephalopathy and the Use of Natalizumab— Unforeseen Consequences. The New England Journal of Medicine, 353, 414-416.
http://dx.doi.org/10.1056/NEJMe058122
|
[6]
|
Sakai, M., Inoue, Y., Aoki, S., Sirasaka, T., Uehira, T., Takahama, S., et al. (2009) Follow-Up Magnetic Resonance Imaging Findings in Patients with Progressive Multifocal Leukoencephalopathy: Evaluation of Long-Term Survivors under Highly Active Antiretroviral Therapy. Japanese Journal of Radiology, 27, 69-77.
|
[7]
|
Cardoso, F. (2002) HIV-Related Movement Disorders. CNS Drugs, 16, 663-668.
http://dx.doi.org/10.2165/00023210-200216100-00002
|
[8]
|
Sporer, B., Seelos, K., Asmus, F., Boetzel, K. and Pfister, H.-W. (2005) Posterior Fossa Tremor Induced by HIV-Associated Progressive Multifocal Leukoencephalopathy. European Neurology, 53, 96-97.
http://dx.doi.org/10.1159/000085507
|
[9]
|
Tse, W., Cersosimo, M.G., Gracies, J.M., Morgello, S., Olanow, C.W. and Koller, W. (2004) Movement Disorders and AIDS: A Review. Parkinsonism & Related Disorders, 10, 323-324. http://dx.doi.org/10.1016/j.parkreldis.2004.03.001
|